Log In Sign Up
News Wire / economy

BioNTech To Cut Production Sites In Germany And Singapore

NDR Info Marburg 7d7d Impact 8

BioNTech plans to reduce production capacity at sites in Idar-Oberstein, Marburg, and Singapore. The head of the IG BCE regional district for Rhineland-Palatinate and Saarland, Strasser, criticized BioNTech's decision to cut production at three sites. Strasser described the move as a "ruthless clear-cutting" that endangers Germany's status as a pharmaceutical hub. He stated that politics and society should not simply accept these developments. The company, which saw high profits from mRNA vaccines during the COVID-19 pandemic, is facing an existential threat from job losses. The IG BCE union has announced its intention to resist the decision. The company is reportedly offering a combination of cash and stock for compensation. BioNTech management announced in Mainz that the company plans to reduce its workforce by up to 1,000 positions.

BioNTech plans to reduce production capacity at sites in Idar-Oberstein, Marburg, and Singapore. The head of the IG BCE regional district for Rhineland-Palatinate and Saarland, Strasser, criticized BioNTech's decision to cut production at three sites. Strasser described the move as a "ruthless clear-cutting" that endangers Germany's status as a pharmaceutical hub. He stated that politics and society should not simply accept these developments. The company, which saw high profits from mRNA vaccines during the COVID-19 pandemic, is facing an existential threat from job losses. The IG BCE union has announced its intention to resist the decision. The company is reportedly offering a combination of cash and stock for compensation. BioNTech management announced in Mainz that the company plans to reduce its workforce by up to 1,000 positions. BioNTech plans to end production at sites in Oberstein, Marburg, and Singapore, as well as at the Kurax facility. The IG Bergbau Chemie union criticized the planned closures as a lack of social responsibility and an attack on employees. The union noted that BioNTech earned billions during the COVID-19 pandemic and received millions in state support. They alleged the production cuts are being made to impress shareholders.

Topics

BioNTech restructuring pharmaceuticals

Developing

  1. 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

NDR Info

“Getroffen von den Plänen sind demnach die Produktionsstandorte in Ida-Oberstein, Marburg und Singapur sowie Standorte vom übernommenen Konkurrenten CureVac.”

Radio C

“BioNTech Founders Leave To Start New Company”

Radio D

“BioNTech To Cut Production Sites In Germany And Singapore”

MCOT FM 100.5 News

“BioNTech To Cut Production Sites In Germany And Singapore”

Deutschlandfunk

“Der Impfstoffhersteller BioNTech schließt mehrere Standorte. Betroffen sind die Produktionsstätten im rheinland-pfälzischen Ider-Oberstein, im hessischen Marburg, in Singapur sowie vom übernommenen Konkurrenten CureVac in Tübingen. Der Betrieb werde bis Ende 2027 eingestellt, teilte BioNTech mit, bis zu 1.860.”

Deutschlandfunk

“Betrieb werde bis Ende 2027 eingestellt, teilte BioNTech mit, bis zu 1.860.”

WDR 2

“Der Impfstoffhersteller BioNTech will mehrere Standorte schließen. In Deutschland Ider Oberstein und Marburg. Insgesamt könnten fast 1900 Arbeitsstellen gestrichen werden.”

DLF Nova

“Betroffen sind laut Unternehmen bis zu 1.860 Arbeitsplätze.”

DLF Nova

“in die Krebsforschung investieren. Betroffen sind laut Unternehmen bis zu 1.860 Arbeitsplätze.”

DLF Kultur

“Die Produktionsstätten im rainer-pfälzischen Ider-Oberstein, im hessischen Marburg, in Singapur sowie vom übernommenen Konkurrenten Kiewa in Tübingen. Der Betrieb werde bis Ende 2027 eingestellt, teilte Biontech mit.”

DLF Kultur

“nach eigenen Angaben durch die Standortschließungen jährlich rund 500 Millionen Euro einsparen.”

CNR Voice of China

“BioNTech plans to close multiple production sites in Germany.”

CNR Voice of China

“BioNTech will close multiple production sites in Germany.”

CNR Voice of China

“BioNTech To Close Multiple German Production Sites”

CRI News Radio

“BioNTech To Close Multiple German Production Sites”

CRI News Radio

“那么我觉得可能对阿森纳来说会有一定的触动。就是阿森纳因为现在变成了联赛我多赛一场领先5分,这意味着他们现在联赛真刀就是无需再看其他球队的脸色。”

CRI News Radio

“BioNTech aims to save 500 million Euros through site closures”

RTM Nasional FM

“BioNTech Aims To Save 500 Million Euros Through Site Closures”

MCOT FM 100.5 News

“BioNTech is targeting savings of 500 million euros through the closure of certain sites.”

MCOT FM 100.5 News

“BioNTech aims to save 500 million euros through site closures.”

CRI News Radio

“那么我觉得可能阿森纳过去的这场比赛的数字或者说胜率可能给我个人的信心来说还是更高一些。所以这场比赛我更多的是看好主场作战的阿森纳能够进入这场欧冠决赛。好的,非常感谢于超老师。我们从中超的赛场讲到了欧冠的赛场,尤其是再次提醒各位球迷,北京时间明天凌晨3点欧冠半决赛四回合,阿森纳回到主场再战马。”

CNR Voice of China

“BioNTech aims to save 500 million euros through site closures.”

CRI News Radio

“BioNTech plans to close sites as part of a strategy to save approximately 500 million euros.”

DLF Kultur

“according to its own information, through site closures, saving around 500 million euros annually.”

CRI News Radio

“Ergo Aims For 600 Million Euro Savings By 2030”

MCOT FM 100.5 News

“今年,奥萨摩托车在全国各地展示了来自泰国新闻中心的新闻。”

DLF Nova

“Der Impfstoffhersteller BioNTech hat angekündigt, mehrere Produktionsstandorte zu schließen. Das Unternehmen will Geld sparen und mehr in die Krebsforschung investieren. Betroffen sind bis zu 1860 Jobs.”

MCOT FM 100.5 News

“BioNTech To Close Multiple Production Sites”

SWR Aktuell

“Sie spricht von einem, Zitat, skrupellosen Kahlschlag. Das gefährdet den Pharmastandort Deutschland. Politik und Gesellschaft dürften das nicht einfach ackerschluckend zur Kenntnis nehmen, so der Leiter des IGB-CI-Landesbezirks Rheinland-Pfalz-Saarland, Strasser.”

hr-iNFO

“In Marburg hat BioNTech seit der Corona-Pandemie vor allem mRNA-Impfstoffe hergestellt und damit hohe Gewinne gemacht. Inzwischen schreibt der Konzern aber deutlich Verluste und begründet damit den Abbau von weltweit 1.860 Arbeitsplätzen.”

hr-iNFO

“das Management des Unternehmens heute in Mainz angekündigt. Insgesamt bis zu 1.000.”

Deutschlandfunk

“Produktionsstandort in Oberstein, Marburg und Singapur sowie an der Kurax-Stätte zu beenden. [...] Die Gewerkschaft IG Bergbau Chemie kritisiert die geplanten Standortschließungen als gesellschaftliche Verantwortungslosigkeit und Frontalangriff auf die Beschäftigten.”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade